Cargando…
Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab
BACKGROUND: Immune checkpoint inhibitors (ICPIs), used to treat different advanced malignancies, are associated with a wide range of immune-related adverse reactions (irAEs) that deserve close monitoring of patients. Gastrointestinal reactions and hepatotoxicity may occur, which warrant careful eval...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380028/ https://www.ncbi.nlm.nih.gov/pubmed/30777137 http://dx.doi.org/10.1186/s40425-019-0532-1 |